Literature DB >> 10804212

Wild-type huntingtin protects from apoptosis upstream of caspase-3.

D Rigamonti1, J H Bauer, C De-Fraja, L Conti, S Sipione, C Sciorati, E Clementi, A Hackam, M R Hayden, Y Li, J K Cooper, C A Ross, S Govoni, C Vincenz, E Cattaneo.   

Abstract

Expansion of a polyglutamine sequence in the N terminus of huntingtin is the gain-of-function event that causes Huntington's disease. This mutation affects primarily the medium-size spiny neurons of the striatum. Huntingtin is expressed in many neuronal and non-neuronal cell types, implying a more general function for the wild-type protein. Here we report that wild-type huntingtin acts by protecting CNS cells from a variety of apoptotic stimuli, including serum withdrawal, death receptors, and pro-apoptotic Bcl-2 homologs. This protection may take place at the level of caspase-9 activation. The full-length protein also modulates the toxicity of the poly-Q expansion. Cells expressing full-length mutant protein are susceptible to fewer death stimuli than cells expressing truncated mutant huntingtin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10804212      PMCID: PMC6772672     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.

Authors:  Y P Goldberg; D W Nicholson; D M Rasper; M A Kalchman; H B Koide; R K Graham; M Bromm; P Kazemi-Esfarjani; N A Thornberry; J P Vaillancourt; M R Hayden
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?

Authors:  S S Sisodia
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

3.  Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization.

Authors:  A Sawa; G W Wiegand; J Cooper; R L Margolis; A H Sharp; J F Lawler; J T Greenamyre; S H Snyder; C A Ross
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

4.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease.

Authors:  V O Ona; M Li; J P Vonsattel; L J Andrews; S Q Khan; W M Chung; A S Frey; A S Menon; X J Li; P E Stieg; J Yuan; J B Penney; A B Young; J H Cha; R M Friedlander
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.

Authors:  J K White; W Auerbach; M P Duyao; J P Vonsattel; J F Gusella; A L Joyner; M E MacDonald
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Non-virally mediated gene transfer into human central nervous system precursor cells.

Authors:  E Cattaneo; L Conti; A Gritti; P Frolichsthal; S Govoni; A Vescovi
Journal:  Brain Res Mol Brain Res       Date:  1996-11

Review 7.  Huntington's disease: translating a CAG repeat into a pathogenic mechanism.

Authors:  M E MacDonald; J F Gusella
Journal:  Curr Opin Neurobiol       Date:  1996-10       Impact factor: 6.627

8.  Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.

Authors:  M Kim; H S Lee; G LaForet; C McIntyre; E J Martin; P Chang; T W Kim; M Williams; P H Reddy; D Tagle; F M Boyce; L Won; A Heller; N Aronin; M DiFiglia
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

9.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

Authors:  J Nasir; S B Floresco; J R O'Kusky; V M Diewert; J M Richman; J Zeisler; A Borowski; J D Marth; A G Phillips; M R Hayden
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

View more
  115 in total

1.  Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease.

Authors:  J M Lecerf; T L Shirley; Q Zhu; A Kazantsev; P Amersdorfer; D E Housman; A Messer; J S Huston
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells.

Authors:  Ferdinando Squitieri; Vittorio Maglione; Sara Orobello; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2011-04-26       Impact factor: 3.575

Review 3.  Huntingtin in health and disease.

Authors:  Anne B Young
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

4.  Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI).

Authors:  Moumita Datta; Nitai P Bhattacharyya
Journal:  J Biol Chem       Date:  2011-08-06       Impact factor: 5.157

5.  Moving toward a gene therapy for Huntington's disease.

Authors:  J C Glorioso; J B Cohen; D L Carlisle; I Munoz-Sanjuan; R M Friedlander
Journal:  Gene Ther       Date:  2015-12       Impact factor: 5.250

Review 6.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

7.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 8.  Huntington's Disease and Mitochondria.

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi
Journal:  Neurotox Res       Date:  2017-06-21       Impact factor: 3.911

Review 9.  Mutant huntingtin and mitochondrial dysfunction.

Authors:  Ella Bossy-Wetzel; Alejandra Petrilli; Andrew B Knott
Journal:  Trends Neurosci       Date:  2008-10-24       Impact factor: 13.837

10.  Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.

Authors:  Justin Y Chen; Miloni Parekh; Hadear Seliman; Dariya Bakshinskaya; Wei Dai; Kelvin Kwan; Kuang Yu Chen; Alice Y C Liu
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.